PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

Inclusion Criteria: * Patients hospitalized either in the ICU or ward, with a diagnosis of pneumonia, complicated abdominal infections, or complicated urinary tract infection using the protocol-defined Guidelines for Diagnosis Exclusion Criteria: * Pregnant or lactating females * Allergies to Doripenem or its derivatives * Infected by a bacteria that is resistant to Doripenem * Taking probenecid * Severe allergies to other antibiotics like penicillins, cephalosporins, or carbapenems * Severe kidney disease, in an unstable disease state and assessed as unlikely to survive until the study follow up period * Signs of severe sepsis with treatment failure with other carbapenems, who received other carbapenem within 2 weeks before first dose of study drug, and who has any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements